ADVATx

The future of professional skin rejuvenation

Clinically proven dye laser wavelength of 589 nm for the first time as a solid-state laser without consumables.
A versatile dermatological laser system for the treatment of acne, rosacea, vascular and pigmented skin changes as well as for skin tightening and improving skin texture. The 589 nm wavelength specifically addresses vascular and pigment structures, while 1319 nm works deeper in the dermis and supports the formation of new collagen.

Request information

Description of the

ADVATx is a dermatological laser system that first provides the 589 nm dye laser wavelength using modern solid-state and diode laser technology.

In contrast to traditional dye lasers, ADVATx operates without dyes, consumables, or complex maintenance processes, which ensures high operational reliability and cost-effectiveness.
The 589 nm wavelength exhibits selective absorption by haemoglobin and epidermal melanin, making it suitable for treating vascular lesions, inflammatory dermatoses such as acne and rosacea, and pigmented lesions including melasma.
The additional 1319 nm wavelength penetrates deeper into the dermis, enabling controlled thermal stimulation of dermal structures. It is used to treat scars, skin laxity, and wrinkles, and supports structural skin improvement.
Through the combined application of both wavelengths, ADVATx presents a versatile, cross-indication laser system with high clinical efficacy, good treatment comfort, and minimal downtime.

Treatment options

589 nm – Vascular, inflammatory, and pigmented skin lesions
(Medical CE- and FDA-approved applications)

Inflammatory acne (Acne vulgaris)
Rosacea
Teleangiectasias (face & legs)
Spider veins (face & legs)
Port-Wine-Stains
Haemangiomas
Venous Lakes
Angiomas

Poikiloderma of Civatte
Pigmented lesions and hyperpigmentations
Melasma
Warts
Psoriasis
Wrinkles, including periorbital and periocular areas
Skin Rejuvenation

1319 nm – Dermal Regeneration and Structural Skin Improvement
(Medical CE- and FDA-approved applications)

Fine lines and wrinkles
Skin rejuvenation
Atrophic acne scars
Reduction of acne scars

Mild to moderate inflammatory acne
Pore size reduction
Improvement of skin structure and firmness

Technology & active principle

The combination of 589 nm and 1319 nm enables indication-specific treatment of various skin structures at different tissue depths.

The 589 nm wavelength corresponds to the clinically established dye laser wavelength and is selectively absorbed by haemoglobin and epidermal melanin. It is particularly suitable for treating vascular skin lesions, inflammatory processes, and pigmented lesions, such as those occurring with rosacea, acne, and hyperpigmentations, among others.

The 1319 nm wavelength penetrates deeper into the dermis and primarily acts on water-containing structures. This achieves controlled thermal stimulation of the dermal tissue, which promotes the regeneration of collagen and elastin, leading to improved skin texture, firmness, and pore size.
The combined application of both wavelengths allows both superficial and deeper skin layers to be addressed in a single treatment.
ADVATx thus enables effective, safe, and comfortable treatments with no social downtime and high clinical reproducibility.

Technical data

System name: ADVATx®
Technology: Combination of Solid-State (Crystal / Solid-State) and Diode Laser Technology
Wavelengths 589 nm and 1319 nm
Spot size 1 mm
Scanner: Integrated scanner
Scan pattern: 1–10 mm (circle, line, square)
Fluence area:
589 nm: 5–60 J/cm²
1319 nm: 5–60 J/cm²
Depth of treatment:
589 nm: superficial vascular and pigment structures
1319 nm: dermal structures

Treatment mode: Soft pulsing / nanopulse sequences
Cooling / Anaesthesia: not required
Consumables: none
Weight: approx. 63 kg
Downtime: No social downtime
Maintenance: Low maintenance, no dye or filter changes
Certifications: Medical CE (CE 0459) and FDA-approved

Handpieces and filters

The handpiece of the ADVATx system is designed for precise dermatological laser applications with high reproducibility.
It works with a precisely defined spot size of 1 mm and an integrated spacer that ensures a constant treatment distance to the skin surface.
This ensures uniform fluency and controlled energy delivery to the target structure, particularly when treating small, well-defined lesions.
The handpiece supports standardised treatment protocols and safe clinical use.